News
NXL
2.950
+2.43%
0.070
Weekly Report: what happened at NXL last week (1216-1220)?
Weekly Report · 6d ago
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic
Barchart · 6d ago
Nexalin Technology files to sell 2.8M shares of common stock for holders
TipRanks · 12/20 17:40
Weekly Report: what happened at NXL last week (1209-1213)?
Weekly Report · 12/16 11:11
Weekly Report: what happened at NXL last week (1202-1206)?
Weekly Report · 12/09 11:10
Nexalin Technology Cut to Hold From Buy by Maxim Group
Dow Jones · 12/05 20:21
Maxim Group Downgrades Nexalin Technology to Hold
Benzinga · 12/05 20:11
Nexalin Technology downgraded to Hold from Buy at Maxim
TipRanks · 12/05 12:45
Weekly Report: what happened at NXL last week (1125-1129)?
Weekly Report · 12/02 11:10
Nexalin Technology, Inc. Announces Validation of DIFS Technology in Peer-Reviewed Editorial on Psychiatric Treatment
Barchart · 11/26 19:12
Nexalin Technology announces peer-reviewed publication on DIFS technology
TipRanks · 11/26 15:06
Weekly Report: what happened at NXL last week (1118-1122)?
Weekly Report · 11/25 11:02
Weekly Report: what happened at NXL last week (1111-1115)?
Weekly Report · 11/18 10:59
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
Benzinga · 11/11 14:49
Nexalin Technology releases letter to shareholders
TipRanks · 11/11 13:31
Nexalin Technology CEO Highlights Breakthroughs In DIFS For Alzheimer's And MDD; New Patent Granted, Clinical Trial Launched For Veterans With mTBI, And Global Regulatory Approvals Expanded With First Latin American Clearance
Benzinga · 11/11 13:17
Weekly Report: what happened at NXL last week (1104-1108)?
Weekly Report · 11/11 11:11
Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities
TipRanks · 11/10 06:01
Based on the provided financial report articles, I generated the title for the article: **"NXL: Common Stock, Warrants, and Financial Statements for Q3 2024"** Please note that the title is generated based on the content provided, and it may not be the exact title used in the original article.
Press release · 11/09 00:36
(NXL) - Analyzing Nexalin Technology's Short Interest
Benzinga · 11/07 19:45
More
Webull provides a variety of real-time NXL stock news. You can receive the latest news about Nexalin Tech through multiple platforms. This information may help you make smarter investment decisions.
About NXL
More
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. It also has designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Generation 3 or Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.